Picture Berlin Partner BIO 2024 International Convention San Diego 650x100px

Organisation › Details

Myelo Therapeutics GmbH

https://www.myelotherapeutics.com

Myelo Therapeutics is a pharmaceutical company based at the Biotech Park Berlin-Buch, Germany that is developing innovative treatments in areas of high unmet medical needs. *

	Start	2013-04-30 established
	Group	Eckert & Ziegler (Group)
	Industry	cancer drug
	Industry 2	drug development
	Person	Pleimes, Dirk (Myelo Therapeutics 201304– Managing Director + Co-Founder)
	Person 2	Steeger, Anna (Myelo Therapeutics 202311 Managing Director)

	Region	Berlin
	Country	Germany
	Street	7 Rheinsberger Str.
	City	10115 Berlin
	Tel	+49-30-6890-8696
		Address record changed: 2023-11-11

Basic data	Employees	n. a.

		* Document for »About Section«:

		Record changed: 2023-12-30

Picture Berlin Partner BIO 2024 International Convention San Diego 650x200px

More documents for Eckert & Ziegler (Group)

[1] Eckert & Ziegler AG. (1/8/24). "Press Release: Eckert & Ziegler and ArtBio Announce Manufacturing and Supply Partnership for Lead-212 Conjugates". Berlin & Cambridge, MA....
[2] Eckert & Ziegler AG. (11/14/23). "Press Release: Eckert & Ziegler Establishes German-Chinese Joint Venture with DC Pharma for the Production of Radioisotopes". Berlin....
[3] Eckert & Ziegler AG. (9/25/23). "Press Release: Eckert & Ziegler Signs Strategically Important Agreement for the Supply of Lutetium-177 with POINT Biopharma". Berlin....
[4] Eckert & Ziegler AG. (5/15/23). "Press Release: Reorganization in the Executive Board of Eckert & Ziegler". Berlin....
[5] Eckert & Ziegler AG. (4/4/23). "Press Release: Eckert & Ziegler to Supply Point Biopharma with Actinium-225". Berlin & Indianapolis, IN....
[6] Eckert & Ziegler Strahlen- und Medizintechnik AG. (12/19/22). "Press Release: Changes in the Management Board of Eckert & Ziegler. Insider Information Pursuant to Article 17 MAR". Cambridge....
[7] Precirix N.V.. (9/12/22). "Press Release: Precirix Enters into Collaboration with Eckert & Ziegler for the Development of Its 68Ga-based Compounds". Brussels & Berlin....
[8] Precirix N.V.. (7/26/22). "Press Release: Precirix and Eckert & Ziegler Sign Agreement on Priority Supply of the Therapeutic Radioisotope Actinium-225". Brussels & Berlin....
[9] Myelo Therapeutics GmbH. (9/25/18). "Press Release: FDA Grants Myelo Therapeutics Orphan Drug Designation for Myelo001 as Treatment for Acute Radiation Syndrome". Berlin....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]